Peter Salzmann - Aug 3, 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Executive Officer, Director
Signature
/s/ Pamela Yanchik Connealy, attorney-in-fact for Peter Salzmann
Stock symbol
IMVT
Transactions as of
Aug 3, 2021
Transactions value $
$0
Form type
4
Date filed
8/4/2021, 04:06 PM
Previous filing
Jun 17, 2021
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +571K +430.65% $0.00 703K Aug 3, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 37.5% of the RSUs will vest on January 1, 2022 and the remainder of the RSUs will vest on August 3, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date.